Pharmacopeia
DIGOXIN
Core pharmacology
- Class Group
Antiarrhythmic –
Vaughan Williams Class V
Other- Introduction
glycoside derived from the dried leaves of the foxglove
Block Na-K-ATPase pump
- Indications Uses
used in AF and atrial flutter, SVT and in heart failure
- Presentation
PO: tablets 62.5mcg or 250mcg. IV:25-250mcg/ml.
Narrow therapeutic window. Monitoring necessary - 0.5-2mcg/L(~1)- Mechanism of action
i) Na/K ATPase inhibition → ↑ intracell Na → ↓ Na-Ca pump → ↑ intracell Ca → inotropy
ii) direct: ↑ AV node ERP, ↓ V ERP
iii) Indirect: Via Vagus – bradycardia, ↓ A refr. Augmentn of direct ↑ AV node ERP- Onset Peak Duration
onset / duration Oral: 1-2 hours; I.V.: 5-60 mins / 3-4 days
- Adverse Effects Toxicity
Thyroid-Vd
Narrow therapeutic window -monitoring - 0.5-2mcg/L(~1)
Toxic > 2.5- arrhythmias, AV block.
anorexia,N/V/D, lethargy. Altered Red green colour perception. ECG: ↑ PR, ST dep, T fl-attening, ↓QT. (may not indicate toxicity)- Absorption
IV, PO BA 60-80%
- Protein binding
prot bind ~25%; uremia- displaced fm pl prot bind sites
- Volume of distribution
6-7 L/kg
thyroid (↑ in hyper, ↓ hypo).- Metabolism
Stomach:Sequential sugar hydrolysis+ redn of lactone ring by intestinal bacteria
min hepatic, most excr unchanged- Excretion
Urine (50% to 70% unchanged)
- Half-life
36-48 hours
- Route And Dose
IV/PO.
loading 250-500mcg QID then 62.5-125mcg daily
Cardiovascular · Cardiovascular
- Legacy Cicm Level
Level 1
- Physiological effects
Effects: Inotropy
Direct and indirect effects on refractory period + bradycardia -> treat AF&flutter- Legacy Cicm Level
Level 3
- Physiological effects
CVS
- The main action of digoxin is to increase the force of cardiac contraction; automaticity and contractility also increase.
- The heart rate is slowed due to a combination of improved haemodynamics, depression of sinus node discharge, slowing of AV nodal conduction, an increase in the AV nodal refractory period, and an indirect vagotonic effect.
- Rapid intravenous administration of digoxin may cause vasoconstriction, leading to hypertension and decreased coronary blood flow.
- The characteristic ECG changes produced by the drug include prolongation of the PR interval, ST-segment depression, T-wave flattening, and shortening of the QT intervalGIT - Anorexia/N/V/Diarrhoea (especially if therapeutic range exceeded)
CNS
- Headache, confusion, coma (toxicity)
- Visual disturbances (deranged red-green colour perception)Renal- Mild diuretic effect
Miscellaneous- Rashes, eosinophilia; Gynaecomastia